lomustine has been researched along with Invasiveness, Neoplasm in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adult patients (≥18 years of age) with a first recurrence of a glioblastoma after temozolomide chemoradiotherapy were randomly allocated by a web-based program to treatment with oral lomustine 110 mg/m(2) once every 6 weeks, intravenous bevacizumab 10 mg/kg once every 2 weeks, or combination treatment with lomustine 110 mg/m(2) every 6 weeks and bevacizumab 10 mg/kg every 2 weeks." | 9.19 | Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial. ( Beerepoot, LV; Boerman, D; Brandsma, D; Bromberg, JE; Buter, J; de Vos, FY; Dinjens, WN; Dubbink, HJ; Enting, RH; Hanse, MC; Honkoop, AH; Jansen, RL; Oosterkamp, HM; Taal, W; Taphoorn, MJ; van den Bent, MJ; van den Berkmortel, FW; van der Holt, B; van Heuvel, I; Vernhout, RM; Walenkamp, AM, 2014) |
| " Adult patients (≥18 years of age) with a first recurrence of a glioblastoma after temozolomide chemoradiotherapy were randomly allocated by a web-based program to treatment with oral lomustine 110 mg/m(2) once every 6 weeks, intravenous bevacizumab 10 mg/kg once every 2 weeks, or combination treatment with lomustine 110 mg/m(2) every 6 weeks and bevacizumab 10 mg/kg every 2 weeks." | 5.19 | Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial. ( Beerepoot, LV; Boerman, D; Brandsma, D; Bromberg, JE; Buter, J; de Vos, FY; Dinjens, WN; Dubbink, HJ; Enting, RH; Hanse, MC; Honkoop, AH; Jansen, RL; Oosterkamp, HM; Taal, W; Taphoorn, MJ; van den Bent, MJ; van den Berkmortel, FW; van der Holt, B; van Heuvel, I; Vernhout, RM; Walenkamp, AM, 2014) |
| "Nine patients with stage III and stage IV thymoma were treated with cisplatin, vincristine, lomustine, cyclophosphamide and prednisolone." | 3.69 | Combination chemotherapy with a five-drug regimen for invasive thymoma. ( Bjerrum, OW; Daugaard, G; Kiss, K, 1996) |
| "Forty patients with invasive bladder tumors were consecutively treated and followed between June 1986 and February 1993." | 2.67 | Combined immunochemotherapy (CEP, M-VEP + BCG) in the treatment of invasive bladder tumors. ( Chuchkova, M; Damianov, C; Koleva, P; Terziev, T, 1994) |
| "Malignant gliomas are the most common primary intrinsic brain tumors and are highly lethal." | 1.35 | Nitrosoureas inhibit the stathmin-mediated migration and invasion of malignant glioma cells. ( Choi, Y; Liang, XJ; Park, JK; Sackett, DL, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shih, JL | 1 |
| Brenn, S | 1 |
| Schrope, DP | 1 |
| Taal, W | 1 |
| Oosterkamp, HM | 1 |
| Walenkamp, AM | 1 |
| Dubbink, HJ | 1 |
| Beerepoot, LV | 1 |
| Hanse, MC | 1 |
| Buter, J | 1 |
| Honkoop, AH | 1 |
| Boerman, D | 1 |
| de Vos, FY | 1 |
| Dinjens, WN | 1 |
| Enting, RH | 1 |
| Taphoorn, MJ | 1 |
| van den Berkmortel, FW | 1 |
| Jansen, RL | 1 |
| Brandsma, D | 1 |
| Bromberg, JE | 1 |
| van Heuvel, I | 1 |
| Vernhout, RM | 1 |
| van der Holt, B | 1 |
| van den Bent, MJ | 1 |
| Liang, XJ | 1 |
| Choi, Y | 1 |
| Sackett, DL | 1 |
| Park, JK | 1 |
| Agha, CA | 1 |
| Ibrahim, S | 1 |
| Hassan, A | 1 |
| Elias, DA | 1 |
| Fathallah-Shaykh, HM | 1 |
| Chamberlain, MC | 2 |
| Damianov, C | 1 |
| Terziev, T | 1 |
| Koleva, P | 1 |
| Chuchkova, M | 1 |
| Packer, RJ | 1 |
| Sutton, LN | 1 |
| Elterman, R | 1 |
| Lange, B | 1 |
| Goldwein, J | 1 |
| Nicholson, HS | 1 |
| Mulne, L | 1 |
| Boyett, J | 1 |
| D'Angio, G | 1 |
| Wechsler-Jentzsch, K | 1 |
| Bjerrum, OW | 1 |
| Kiss, K | 1 |
| Daugaard, G | 1 |
| Greenberg, HS | 1 |
| Glantz, MJ | 1 |
| Wang, S | 1 |
| Barth, RJ | 1 |
| Venzon, DJ | 1 |
| Baker, AR | 1 |
| Albers, GW | 1 |
| Hoyt, WF | 1 |
| Forno, LS | 1 |
| Shratter, LA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Study of Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma[NCT02698280] | Phase 2 | 23 participants (Actual) | Interventional | 2015-07-31 | Completed | ||
| Temozolomide Plus Bevacizumab Chemotherapy in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status (KPS<70)[NCT02898012] | Phase 2 | 70 participants (Actual) | Interventional | 2010-10-31 | Completed | ||
| An International, Randomized, Open-label Phase I/II Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Adult Patients With Recurrent or Refractory Medulloblastomas Presenting an Activation of the Sonic Hedgehog (SHH) Pathway[NCT01601184] | Phase 1/Phase 2 | 24 participants (Actual) | Interventional | 2012-06-30 | Terminated (stopped due to The number of successes is not reached at the end of first stage of the phase II. The study is stopped.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for lomustine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Adult medulloblastoma: multiagent chemotherapy.
Topics: Abdominal Pain; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebrospinal Flu | 2001 |
3 trials available for lomustine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Topics: Administration, Oral; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neopl | 2014 |
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Topics: Administration, Oral; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neopl | 2014 |
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Topics: Administration, Oral; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neopl | 2014 |
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Topics: Administration, Oral; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neopl | 2014 |
Combined immunochemotherapy (CEP, M-VEP + BCG) in the treatment of invasive bladder tumors.
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vacci | 1994 |
Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherap | 1994 |
7 other studies available for lomustine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Cardiac involvement secondary to mediastinal lymphoma in a cat: regression with chemotherapy.
Topics: Animals; Anticonvulsants; Antineoplastic Agents; Asparaginase; Cat Diseases; Cats; Drug Therapy, Com | 2014 |
Nitrosoureas inhibit the stathmin-mediated migration and invasion of malignant glioma cells.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Movement; Glioma; Lomustine; Mice; | 2008 |
Bevacizumab is active as a single agent against recurrent malignant gliomas.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chem | 2010 |
Gliomatosis cerebri: better definition, better treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Astrocyt | 2004 |
Combination chemotherapy with a five-drug regimen for invasive thymoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormon | 1996 |
The prognosis of melanoma patients with metastases to two or more lymph node areas.
Topics: Adolescent; Adult; BCG Vaccine; Combined Modality Therapy; Dacarbazine; Female; Humans; Immunotherap | 1991 |
Treatment response in malignant optic glioma of adulthood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cranial Nerve Neoplasms; F | 1988 |